Immunocore Statistics
NASDAQ: IMCRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
29.41-0.14 (-0.47%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Immunocore by the numbers
Immunocore has a market capitalization of $1.51 billion based on 51.50M shares outstanding. With trailing EPS of $-0.36, Immunocore is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.7% below its 50-day average and 8.3% below its 200-day average.
Average daily trading volume is 447.09K shares, or about $13.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMCR valuation vs. peer median
| Metric | IMCR | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.51B | $1.41B | +8% |
| Avg. volume | 447.09K | 577.67K | -23% |
Peer median across 8 companies: MAZE, TSHA, INBX, COAG, REPL, MESO, NVAX, IMTX.
Valuation
- Market cap
- $1.51B
- EPS (TTM)
- $-0.36
- Shares outstanding
- 51.50M
Price and trading
- Previous close
- 29.55
- Open
- 29.55
- Day range
- 29.15 – 29.82
- 52-week range
- 27.56 – 40.72
- 52-week change
- -14.06%
- Beta
- —
- Volume
- 343.75K
- Average volume
- 447.09K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.51B
- Forward Pe
- -38.98
- Eps
- -0.36
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.72
- Week52 Low
- 27.56
- Avg Volume
- 447.09K
- Shares Outstanding
- 51.50M
- Ma50
- 33.69
- Ma200
- 32.09
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -27.77%
- Pct From52w Low
- 6.73%